肉汤微量稀释
茴香菌素
伏立康唑
微生物学
伊曲康唑
烟曲霉
两性霉素B
生物
最小抑制浓度
曲霉
医学
抗真菌
卡斯波芬金
抗菌剂
作者
Ali Nuh,Newara Ramadan,Silke Schelenz,Darius Armstrong‐James
出处
期刊:Medical Mycology
[Oxford University Press]
日期:2020-04-03
卷期号:58 (8): 1085-1090
被引量:8
摘要
The aim of this study was to evaluate a colorimetric method, MIRONAUT-AM, for determining susceptibility testing of anidulafungin, amphotericin, voriconazole, and itraconazole by comparing the minimum inhibitory (effective) concentrations (MICs/MECs) obtained by this method to those generated by the reference Clinical Laboratory Standard Institute (CLSI) broth microdilution method. In sum, 78 clinical isolates of Aspergillus species, nine of them non-wild type (non-WT) with itraconazole MIC ranging from 2 mg/l to >16 mg/l, were tested against above antifungals. A. fumigatus ATCC 204305 was used as a reference strain, and test was performed in accordance with slightly modified yeast susceptibility testing instruction of the manufacture; conidia suspension inoculum and alamarBlue concentration were optimized. These same isolates were referred to Bristol Mycology reference laboratory and tested by CLSI method. The MICs and MECs generated by the two methods were compared using concordance analysis. MIRONAUT-AM showed significant concordance (P < .0001) with CLSI method, and overall agreement was high (≥90%). In addition, MIRONAUT-AM produced echinocandin MECs results within 18-24 hours incubation time and correctly detected all non-WT isolates except one isolate. This colorimetric method is very promising and appears to be a suitable alternative susceptibility testing method to labor intensive broth microdilution reference method for Aspergillus species.
科研通智能强力驱动
Strongly Powered by AbleSci AI